Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.85 is 47% above its 5-year average of 1.94, near the high end of its 5-year range (0.64–3.40).
As of the fiscal period ended Tuesday, June 30, 2026. 23.68% above its 12-month average of 2.30.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.85.
CURRENT RATIO
2.85
CURRENT RATIO AVG TTM
2.30
CURRENT RATIO AVG 3Y
2.08
CURRENT RATIO AVG 5Y
1.94
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+23.68%
CURRENT VS 3Y AVG
+36.85%
CURRENT VS 5Y AVG
+46.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.08
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
-7.50%
vs the sector median at left
Market Cap
$244.25M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$245.65M
Current Ratio
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$248.21M
Current Ratio
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$251.64M
Current Ratio
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biodesix, Inc. (BDSX) | $236.56M | 2.85 | 2.30 | 2.08 | 1.94 |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | 17.19 | 13.55 | 8.08 | 8.08 |
| High Tide Inc. (HITI)vs › | $239.89M | 1.50 | 1.39 | 1.25 | 1.14 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 1.43 | 1.27 | 1.29 | 1.36 |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | 0.10 | 1.46 | 1.56 | 2.73 |
| InflaRx N.V. (IFRX)vs › | $247.45M | 8.22 | 4.59 | 5.79 | 6.14 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 1.54 | 1.17 | 19.33 | 29.22 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | 4.70 | 7.13 | 7.51 | 5.68 |
| Alector, Inc. (ALEC)vs › | $220.94M | 5.26 | 3.62 | 4.54 | 4.95 |
| Compugen Ltd. (CGEN)vs › | $218.42M | 5.72 | 5.91 | 5.85 | 7.15 |
Current Ratio
2.85
Quick Ratio
2.85
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.85 |
| 2026-03-31 | 2.82 |
| 2025-12-31 | 1.86 |
| 2025-09-30 | 1.84 |
| 2025-06-30 | 2.14 |
| 2025-03-31 | 2.22 |
| 2024-12-31 | 2.76 |
| 2024-09-30 | 3.40 |
| 2024-06-30 | 3.28 |
| 2024-03-31 | 0.91 |
| 2023-12-31 | 1.19 |
| 2023-09-30 | 0.88 |
| 2023-06-30 | 0.90 |
| 2023-03-31 | 1.57 |
| 2022-12-31 | 2.34 |
| 2022-09-30 | 0.64 |
| 2022-06-30 | 1.06 |
| 2022-03-31 | 0.91 |
| 2021-12-31 | 1.51 |
| 2021-09-30 | 2.48 |
| 2021-06-30 | 3.22 |
| 2021-03-31 | 5.04 |
| 2020-12-31 | 2.68 |
| 2020-09-30 | 0.32 |
| 2020-06-30 | 1.28 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.56 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
